Literature DB >> 3260527

A further study of the neuromuscular effects of vesamicol (AH5183) and of its enantiomer specificity.

D Estrella1, K L Green, C Prior, J Dempster, R F Halliwell, R S Jacobs, S M Parsons, R L Parsons, I G Marshall.   

Abstract

1. The effects of vesamicol (2-(4-phenylpiperidino) cyclohexanol), an inhibitor of acetylcholine storage, and its two optical isomers have been studied on neuromuscular transmission in rat and frog muscle, and on nerve conduction in frog nerve. 2. Racemic vesamicol produced a pre-block augmentation of twitch tension that also occurred in directly-stimulated muscle. This effect is thus at least partially due to an increase in muscle contractility. 3. (-)-Vesamicol was approximately 20 times more potent than (+)-vesamicol in blocking twitches elicited at 1 Hz. This degree of stereoselectivity is similar to that measured for inhibition of acetylcholine uptake by isolated synaptic vesicles. Both enantiomers were equally weak in reducing nerve action potential amplitude in frog nerve. 4. Further studies with the active isomer, (-)-vesamicol, showed that, like that produced by racemic vesamicol, the neuromuscular block was highly frequency-dependent. The block was not reversed by choline or neostigmine, but was partially reversed by 4- or 3,4-aminopyridine. 5. Preliminary electrophysiological studies showed that vesamicol reduced miniature endplate potential amplitude in rapidly-stimulated frog nerve-muscle preparations. Addition of lanthanum ions increased the frequency of miniature endplate potentials and led to the appearance of apparently normal-sized potentials amongst those of reduced amplitude. 6. The results show the close agreement between pharmacological and biochemical observations indicating the suitability of the rat diaphragm as a test model for substances of this nature. The degree of reversibility of the vesamicol-induced neuromuscular block by aminopyridines was unexpected, and it is suggested that in the presence of a drug which greatly increases release, a pool of acetylcholine is capable of being released which is not normally releasable after block of storage by vesamicol. It is also considered possible that the results from the intracellular recording studies may be explained in these terms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260527      PMCID: PMC1853909          DOI: 10.1111/j.1476-5381.1988.tb11460.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  [Changes in transmitter release at frog neuromuscular junction induced by 4-aminopyridine].

Authors:  J Molgo; M Lemeignan; P Lechat
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1975-11-24

2.  Influence of lanthanum on transmitter release at the neuromuscular junction.

Authors:  W A DeBassio; R M Schnitzler; R L Parsons
Journal:  J Neurobiol       Date:  1971

3.  Effects of lanthanum ions on function and structure of frog neuromuscular junctions.

Authors:  J Heuser; R Miledi
Journal:  Proc R Soc Lond B Biol Sci       Date:  1971-12-14

4.  The neuromuscular blocking action of 2-(4-phenylpiperidino) cyclohexanol (AH 5183).

Authors:  R T Brittain; G P Levy; M B Tyers
Journal:  Eur J Pharmacol       Date:  1969-10       Impact factor: 4.432

5.  Characteristics of postjunctional carbamylcholine receptor activation and inhibition.

Authors:  E W Johnson; R L Parsons
Journal:  Am J Physiol       Date:  1972-03

6.  2-(4-phenylpiperidino) cyclohexanol (AH5183) decreases quantal size at the frog neuromuscular junction.

Authors:  W Van der Kloot
Journal:  Pflugers Arch       Date:  1986-01       Impact factor: 3.657

7.  Studies on the blocking action of 2-(4-phenyl piperidino) cyclohexanol (AH5183).

Authors:  I G Marshall
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

8.  A study of the mechanism of quantal transmitter release at a chemical synapse.

Authors:  Z L Blioch; I M Glagoleva; E A Liberman; V A Nenashev
Journal:  J Physiol       Date:  1968-11       Impact factor: 5.182

9.  Demonstration of a receptor in Torpedo synaptic vesicles for the acetylcholine storage blocker L-trans-2-(4-phenyl[3,4-3H]-piperidino) cyclohexanol.

Authors:  B A Bahr; S M Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  The effect of calcium on the desensitization of membrane receptors at the neuromuscular junction.

Authors:  A A Manthey
Journal:  J Gen Physiol       Date:  1966-05       Impact factor: 4.086

View more
  4 in total

1.  The vesicular acetylcholine transporter is required for neuromuscular development and function.

Authors:  Braulio M de Castro; Xavier De Jaeger; Cristina Martins-Silva; Ricardo D F Lima; Ernani Amaral; Cristiane Menezes; Patricia Lima; Cintia M L Neves; Rita G Pires; Thomas W Gould; Ian Welch; Christopher Kushmerick; Cristina Guatimosim; Ivan Izquierdo; Martin Cammarota; R Jane Rylett; Marcus V Gomez; Marc G Caron; Ronald W Oppenheim; Marco A M Prado; Vania F Prado
Journal:  Mol Cell Biol       Date:  2009-07-27       Impact factor: 4.272

2.  In favour of the vesicular hypothesis: neurochemical evidence that vesamicol (AH5183) inhibits stimulation-evoked release of acetylcholine from neuromuscular junction.

Authors:  E S Vizi
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

3.  The effects of vesamicol on trains of endplate currents and on focally recorded nerve terminal currents at mammalian neuromuscular junctions.

Authors:  K E Pemberton; C Prior; I G Marshall
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

4.  Characterization of [3H]vesamicol binding in rat brain preparations.

Authors:  E M Meyer; S O Bryant; R H Wang; R J Watson
Journal:  Neurochem Res       Date:  1993-10       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.